during the rapidly evolving discipline of most cancers therapeutics, knowledge the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is very important for creating powerful remedies. One of the more promising methods is using in vitro bystander outcome assays, which play a pivotal job in improving therapeutic efficacy. These assays, supplied